Skip to Content

Filter by:

Second Opinion

Learn about policy issues important to medical schools and teaching hospitals, with Executive Vice President Atul Grover, M.D., Ph.D.


Future innovations in health care and prevention require research across a full spectrum of biomedical science, from basic and translational research to implementation science and comparative effectiveness research. 

AAMC advocates for funding and appropriate regulation by major federal agencies and organizations supporting this research, including the National Institutes of Health (NIH), Agency for Healthcare Research and Quality (AHRQ), and the Department of Veterans Affairs (VA).

Ensuring a sustainable research mission is essential to achieve long-term health priorities, develop new therapeutics and preventive measures, focus on patient-centered outcomes, and reduce health disparities. 

We also work to ensure the integrity of biomedical research, especially research involving human subjects, including privacy protections and management of financial conflicts of interest.


Responsible Conduct of Research
Research with AnimalsStem Cell Research and Regenerative Medicine

News and Updates

Preliminary Injunction Issued on Department of Labor Overtime Rule

December 2, 2016

A U.S. District Court in Texas Nov. 22 issued a nationwide preliminary injunction that blocks the Department of Labor's (DOL) overtime rule from going into effect on Dec. 1.

House Overwhelmingly Approves 21st Century Cures Package

December 2, 2016

The House of Representatives Nov. 30 approved, by a vote of 392-26, the 21st Century Cures Act (H.R. 34), which includes new funding for the National Institutes of Health (NIH) and Food and Drug Administration (FDA), as well as mental health provisions and other hospital and health care provisions.

AAMC Submits Comments to the Commission on Evidence-Based Policymaking

November 18, 2016

he AAMC Nov. 14 submitted a letter to the Commission on Evidence-Based Policymaking in response to a Sep. 14 request for comments on how data and research can be used to build evidence, improve public programs, and inform policy design and implementation while protecting confidentiality and privacy. The 15-member bipartisan commission was formed through the Evidence-Based Policymaking Commission Act of 2016 (P.L. 114-211) and the commission’s findings and recommendations will be presented to congress and the president.

House Announces Plan to Punt Spending Bills to March

November 18, 2016

Appropriators will draft a continuing resolution (CR) to extend current funding levels for most federal programs into March, according to a Nov. 17 statement issued by House Appropriations Committee Chair Hal Rogers (R-Ky.).

NIH Holds Stakeholder Meeting for All of Us Research Program

October 28, 2016

The National Institutes of Health (NIH) Oct. 26 held a stakeholder briefing on the Precision Medicine Initiative (PMI) All of Us Research Program (formerly the PMI Cohort Program), the Administration’s ambitious effort to build a million-person research cohort and significantly improve our understanding of health and disease.

On Government Affairs

Research Spectrum

Testimony and Correspondence